For your convenience, we have created interactive editions of several investor documents and packed them into this eKit. These interactive documents are designed for comfortable reading and easy navigation.

Click here to access the investor kit.

Amgen - Recent Press Releases
04/16/15Amgen Announces Webcast Of 2015 First Quarter Financial ResultsPrinter Friendly Version
04/15/15FDA Approves Corlanor® (ivabradine) To Reduce The Risk Of Hospitalization For Worsening Heart Failure In Patients With Chronic Heart FailurePrinter Friendly Version
04/06/15European Commission Approves Amgen's Vectibix® (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal CancerPrinter Friendly Version
03/30/15Amgen To Present At The Goldman Sachs Key Debates In Biosimilars ConferencePrinter Friendly Version
03/30/15FDA Grants Amgen Priority Review for Kyprolis® (Carfilzomib) Supplemental New Drug Application for the Treatment of Relapsed Multiple MyelomaPrinter Friendly Version
03/26/15Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From Cancer® Champion And Joins Nationwide Search For Ten Champions In The Fight Against CancerPrinter Friendly Version
03/25/15The Genomic Portrait of a Nation Printer Friendly Version
03/23/15Amgen To Webcast Investor Call At the 73rd Annual Meeting of the American Academy of DermatologyPrinter Friendly Version
03/20/15Amgen Submits Application For Investigational LDL Cholesterol-Lowering Medication Repatha™ (evolocumab) In JapanPrinter Friendly Version
03/17/15Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of DermatologyPrinter Friendly Version